SC 79: A Specific Small Molecule Akt Activator for Neuroprot
2026-05-18
SC 79 is a potent and selective small molecule Akt activator that enables cytosolic phosphorylation of Akt, supporting neuroprotection in ischemic stroke models. Its unique mechanism, robust in vivo efficacy, and validated safety profile make it a valuable research tool for Akt signaling pathway research and neuronal survival studies.
HDAC Inhibition Reverses EBV-Induced Plasticity in NPC
2026-05-18
This study elucidates how Epstein-Barr virus (EBV) drives dedifferentiation in nasopharyngeal carcinoma (NPC) via LMP1-mediated recruitment of HDACs, resulting in transcriptional repression of CEBPA. The work demonstrates that HDAC inhibition can restore differentiation markers and reduce stem-like properties in NPC, advancing the rationale for epigenetic differentiation therapy in solid tumors.
Digoxin in Translational Research: Beyond Cardiac Boundaries
2026-05-17
This thought-leadership article explores Digoxin’s evolving role in translational research, integrating mechanistic insight, cross-domain antiviral evidence, and strategic guidance. We dissect its Na+/K+ ATPase pump inhibition, highlight competitive and workflow advantages, cite clinical and preclinical benchmarks, and articulate how APExBIO’s high-purity Digoxin empowers next-generation experimental design. The article provides actionable protocol parameters, contextualizes limitations, and projects a visionary yet evidence-based outlook.
Dimethyloxalylglycine (DMOG): Technical Guide and Protocols
2026-05-16
Dimethyloxalylglycine (DMOG) enables precise and reversible stabilization of hypoxia-inducible factors for hypoxia signaling and inflammation research. Researchers can use DMOG to model hypoxic responses in both in vitro and in vivo experiments, but it should not be used for diagnostic or therapeutic purposes. Rigorous attention to solubility, storage, and workflow parameters is essential for consistent results.
Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Precision in
2026-05-15
The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) delivers robust protein phosphatase 1 and 2A inhibition, preserving phosphorylation states during sample preparation. Its dual-component formulation enables comprehensive inhibition of serine/threonine and tyrosine phosphatases, supporting reproducible results in immunoblotting, kinase activity assays, and mass spectrometry. APExBIO’s validated design ensures stability and workflow compatibility for high-fidelity phosphoproteomics.
GW4064: Non-Steroidal FXR Agonist Workflows in Metabolic Res
2026-05-15
GW4064 stands out as a potent, selective non-steroidal FXR agonist optimized for dissecting bile acid and lipid metabolism, as well as advanced fibrosis pathways. This guide distills the latest experimental protocols, troubleshooting strategies, and key innovations—empowering metabolic researchers to achieve robust, reproducible FXR activation.
Tirbanibulin Suppresses HPV Oncoproteins via Src-MEK Pathway
2026-05-14
This study demonstrates that tirbanibulin significantly inhibits cell proliferation and downregulates key oncogenic proteins, including HPV E6/E7, in HPV-18+ HeLa cells by targeting the Src-MEK signaling axis. The findings clarify tirbanibulin's mechanism in HPV-associated cancer models and provide a robust foundation for translational research targeting post-translational regulation in oncogenesis.
Resiniferatoxin as a Precision Tool for TRPV1-Positive Affer
2026-05-14
The reviewed study highlights resiniferatoxin (RTX) as an ultra-potent, selective TRPV1 agonist with a unique ability to chemically inactivate sensory neurons, enabling targeted analgesia without unacceptable side effects. This work clarifies RTX’s mechanistic specificity, therapeutic window, and translational relevance for neuropathic and osteoarthritis pain, as well as emerging clinical applications.
WEHI-539 in Synthetic Lethality: Advanced BCL-XL Inhibition
2026-05-13
Explore how WEHI-539, a potent BCL-XL inhibitor, enables synthetic lethality and advanced apoptosis research. This article offers a unique deep-dive into practical assay decisions and translational strategies that surpass standard methodologies.
Aztreonam: Applied Workflows Against Gram-Negative Bacteria
2026-05-13
Aztreonam, a monocyclic β-lactam antibiotic, offers targeted inhibition of Gram-negative aerobic bacteria with high solubility and stability in research-grade applications. This article delivers stepwise protocols, troubleshooting strategies, and experimental insights leveraging APExBIO’s Aztreonam, translating cutting-edge resistance data into pragmatic assay choices.
Viral Targeting of RIPK3: Mechanisms Regulating Necroptosis
2026-05-12
This study uncovers how orthopoxviruses deploy a viral inducer of RIPK3 degradation (vIRD) to subvert host necroptosis and regulate virus-induced inflammation. These mechanistic insights reveal new connections between viral evasion strategies, ubiquitin-mediated protein degradation, and host immune responses, informing translational approaches in inflammation and antiviral research.
iPSC-Based Drug Prescreening for Ultrarare Disease Patients
2026-05-12
This study introduces a patient-specific induced pluripotent stem cell (iPSC) platform for prescreening drug efficacy in individuals with ultrarare genetic variants, demonstrated through an 18-year-old with Leigh-like syndrome. The platform enabled personalized drug selection, improving metabolic outcomes and offering a model for precision medicine in undiagnosed or poorly characterized diseases.
Dabigatran Etexilate: Oral Anticoagulant Innovation and CYP3
2026-05-11
The referenced clinical review highlights dabigatran etexilate as the first oral direct thrombin inhibitor with predictable pharmacokinetics, rapid onset, and independence from CYP3A-mediated metabolism. These properties address limitations of traditional anticoagulants and have significant implications for drug-drug interaction research and study design.
Superoxide Dismutase (SOD) Activity Assay Kit: Technical Use
2026-05-11
The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) provides researchers with a rapid, quantitative method for assessing SOD enzyme activity in biological samples, supporting studies of oxidative stress and antioxidative defense. It is intended for laboratory research use only and should not be used for diagnostic or clinical purposes. Researchers working outside of oxidative stress or redox biology contexts may find limited applicability.
Dicoumarol Inhibits IRE1α to Mitigate ER Stress-Induced Live
2026-05-10
This study identifies dicoumarol as a novel inhibitor of IRE1α activity, alleviating ER stress-induced acute liver injury in mouse models. The findings showcase an integrated screening strategy and highlight critical mechanisms by which targeting the IRE1α-XBP1 branch of the unfolded protein response can protect hepatic tissue.
470 records 19/32 page Previous Next First page 上5页 1617181920 下5页 Last page